Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Cancer Medicine|October 8, 2022
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxelGuillaume Joe Pegna, Min-Jung Lee, Cody J Peer, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 3, 2026
Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancerAndrew S Mikhail, Sandeep Gurram, Vladimir A Valera, et al.
Cancer|November 14, 2015
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancerAnne M Noonan, Kristen P Bunch, Jin-Qiu Chen, et al.
Breast Cancer Research and Treatment|September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessmentC C O'Sullivan, M Lindenberg, C Bryla, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.
Science Translational Medicine|December 22, 2021
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsMahadev Rao, Scott M Atay, Vivek Shukla, et al.
Pageof 16